Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 147 |
|---|
(No ratings)
Dr. Christine Lee Hann, MD, PHD is an oncologist in Lutherville, MD specializing in oncology (cancer care). Dr. Christine Lee Hann, MD, PHD is affiliated with Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 147 |
|---|
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 135 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 30 |
|---|---|
| Female | 29 |
| Non-Hispanic White | 43 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 38 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 58 |
|---|---|
| High Cholesterol | 57 |
| Stroke | 0 |
| Ischemic Heart Disease | 38 |
| Depression | 27 |
| Chronic Kidney Disease | 20 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 27 |
| Diabetes | 22 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 100 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 32 |
|---|---|
| Female | 26 |
| Non-Hispanic White | 36 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 33 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 71 |
|---|---|
| High Cholesterol | 55 |
| Stroke | 0 |
| Ischemic Heart Disease | 45 |
| Depression | 0 |
| Chronic Kidney Disease | 28 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 34 |
| Diabetes | 33 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 146 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 74 |
|---|---|
| Female | 66 |
| Non-Hispanic White | 98 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 70 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 63 |
|---|---|
| High Cholesterol | 60 |
| Stroke | 0 |
| Ischemic Heart Disease | 43 |
| Depression | 29 |
| Chronic Kidney Disease | 31 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 29 |
| Chronic Obstructive Pulmonary Disease | 40 |
| Diabetes | 29 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 208 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 42 |
|---|---|
| Female | 56 |
| Non-Hispanic White | 69 |
|---|---|
| Black | 17 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 64 |
|---|---|
| From 75 to 84 | 20 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 64 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 0 |
| Ischemic Heart Disease | 45 |
| Depression | 26 |
| Chronic Kidney Disease | 20 |
| Asthma | 38 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 19 |
| Heart Failure | 19 |
| Chronic Obstructive Pulmonary Disease | 38 |
| Diabetes | 27 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 200 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 55 |
|---|---|
| Female | 58 |
| Non-Hispanic White | 79 |
|---|---|
| Black | 21 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 67 |
|---|---|
| From 75 to 84 | 30 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 74 |
|---|---|
| High Cholesterol | 51 |
| Stroke | 0 |
| Ischemic Heart Disease | 53 |
| Depression | 32 |
| Chronic Kidney Disease | 35 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 19 |
| Chronic Obstructive Pulmonary Disease | 44 |
| Diabetes | 29 |
| Dementia | 12 |
| Cancer | 75 |
The top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD during 2018 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 251 |
|---|---|
| hospital care | 39 |
| inpatient care | 39 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 65 |
|---|---|
| Female | 77 |
| Non-Hispanic White | 98 |
|---|---|
| Black | 28 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 72 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 67 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 9 |
| Ischemic Heart Disease | 53 |
| Depression | 26 |
| Chronic Kidney Disease | 37 |
| Asthma | 9 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 12 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 37 |
| Diabetes | 28 |
| Dementia | 13 |
| Cancer | 75 |
The top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD during 2019 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 264 |
|---|---|
| hospital care | 83 |
| inpatient care | 83 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 80 |
|---|---|
| Female | 80 |
| Non-Hispanic White | 113 |
|---|---|
| Black | 26 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 88 |
|---|---|
| From 75 to 84 | 48 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 74 |
|---|---|
| High Cholesterol | 64 |
| Stroke | 0 |
| Ischemic Heart Disease | 58 |
| Depression | 28 |
| Chronic Kidney Disease | 44 |
| Asthma | 8 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 13 |
| Heart Failure | 25 |
| Chronic Obstructive Pulmonary Disease | 32 |
| Diabetes | 39 |
| Dementia | 8 |
| Cancer | 74 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 239 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 48 |
|---|---|
| Female | 55 |
| Non-Hispanic White | 67 |
|---|---|
| Black | 25 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 56 |
|---|---|
| From 75 to 84 | 31 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 67 |
|---|---|
| High Cholesterol | 52 |
| Stroke | 0 |
| Ischemic Heart Disease | 54 |
| Depression | 25 |
| Chronic Kidney Disease | 39 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 13 |
| Heart Failure | 24 |
| Chronic Obstructive Pulmonary Disease | 34 |
| Diabetes | 38 |
| Dementia | 0 |
| Cancer | 75 |
The top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD during 2021 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 293 |
|---|---|
| hospital care | 32 |
| inpatient care | 32 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 51 |
|---|---|
| Female | 86 |
| Non-Hispanic White | 88 |
|---|---|
| Black | 33 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 72 |
|---|---|
| From 75 to 84 | 42 |
| 85 and over | 11 |
| Less than 65 | 12 |
| Hypertension | 69 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 0 |
| Ischemic Heart Disease | 58 |
| Depression | 26 |
| Chronic Kidney Disease | 40 |
| Asthma | 0 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 15 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 31 |
| Diabetes | 31 |
| Dementia | 9 |
| Cancer | 75 |
The top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 212 |
|---|---|
| hospital care | 40 |
| inpatient care | 40 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 59 |
|---|---|
| Female | 69 |
| Non-Hispanic White | 72 |
|---|---|
| Black | 34 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 61 |
|---|---|
| From 75 to 84 | 43 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 72 |
| Stroke | 13 |
| Ischemic Heart Disease | 34 |
| Depression | 33 |
| Chronic Kidney Disease | 26 |
| Asthma | 13 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 21 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 34 |
| Diabetes | 27 |
| Dementia | 9 |
| Cancer | 75 |
The top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD during 2023 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 220 |
|---|---|
| hospital care | 60 |
| inpatient care | 60 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 53 |
|---|---|
| Female | 68 |
| Non-Hispanic White | 85 |
|---|---|
| Black | 19 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 54 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 15 |
| Ischemic Heart Disease | 30 |
| Depression | 29 |
| Chronic Kidney Disease | 29 |
| Asthma | 0 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 17 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 39 |
| Diabetes | 36 |
| Dementia | 10 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
| doctor visit | 294 |
|---|
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 44 |
|---|---|
| Female | 75 |
| Non-Hispanic White | 86 |
|---|---|
| Black | 14 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 60 |
|---|---|
| From 75 to 84 | 41 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 71 |
| Stroke | 13 |
| Ischemic Heart Disease | 34 |
| Depression | 34 |
| Chronic Kidney Disease | 19 |
| Asthma | 0 |
| Osteoperosis | 18 |
| Atrial Fibrilation | 18 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 45 |
| Diabetes | 30 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Christine Lee Hann, MD, PHD for Medicare patients.
The highest averages for the top procedures that Dr. Christine Lee Hann, MD, PHD treated as an oncologist in Lutherville, MD were hospital care and inpatient care.
| doctor visit | 208 |
|---|---|
| hospital care | 50 |
| inpatient care | 50 |
Information about Medicare patients treated by Dr. Christine Lee Hann, MD, PHD.
| Male | 48 |
|---|---|
| Female | 57 |
| Black / African American | 16 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 71 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 27 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 0 |
| 65 to 74 | 56 |
The highest averages of the most common conditions of Medicare patients that Dr. Christine Lee Hann, MD, PHD treated were cancer, hypertension, high cholesterol and ischemic heart disease.
| Hypertension | 64 |
|---|---|
| High Cholesterol | 55 |
| Stroke | 3 |
| Ischemic Heart Disease | 41 |
| Depression | 24 |
| Chronic Kidney Disease | 28 |
| Asthma | 5 |
| Osteoporosis | 4 |
| Heart Failure | 17 |
| Chronic Obstructive Pulmonary Disease | 33 |
| Diabetes | 28 |
| Atrial Fibrillation | 9 |
| Dementia | 4 |
| Cancer | 69 |
She has a state license in Maryland.
Licensed In: Maryland
Dr. Christine Lee Hann, MD, PHD does not have any reviews yet, be the first to leave a review of Dr. Christine Lee Hann, MD, PHD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Christine Lee Hann, MD, PHD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AbbVie, Inc. |
$28,278
$28,278 |
|||||
|---|---|---|---|---|---|---|
| F. Hoffmann-La Roche AG |
$15,080
TECENTRIQ $15,080 |
|||||
| AstraZeneca Pharmaceuticals LP |
$10,728
IMFINZI $8,403 |
$2,325 |
||||
| E.R. Squibb & Sons, L.L.C. |
$7,562
OPDIVO $7,412 |
$149 |
||||
| AbbVie Inc. |
$6,841
$6,841 |
|||||
| Other |
$13,574
TECENTRIQ $3,561 |
IMFINZI $1,370 |
Avastin $85 |
KEYTRUDA $63 |
XPOVIO $12 |
Other $8,482 |
| Consulting Fee | $57,792 |
|---|---|
| Travel and Lodging | $22,206 |
| Food and Beverage | $2,051 |
| Education | $12 |
Dr. Christine Lee Hann, MD, PHD has received 282 research payments totaling $1,739,299.
Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University  follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer.Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research.Specific research projects include:1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103).2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs;3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs.